P06.05 Myoinositol as a predictive baseline biomarker for overall survival of patients with recurrent glioblastoma treated with Bevacizumab: A 1H-magnetic resonance spectroscopy study

P06.05 Myoinositol as a predictive baseline biomarker for overall survival of patients with recurrent glioblastoma treated with Bevacizumab: A 1H-magnetic resonance spectroscopy study

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Vol. 18; no. suppl_4; p. iv28
Main Authors: Steidl, E., Pilatus, U., Steinbach, J. P., Zanella, F., Ronellenfitsch, M. W., Hattingen, E., Bähr, O.
Format: Journal Article
Language:English
Published: US Oxford University Press 01-10-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/now188.096